Table of Content 1 Industry Overview 1.1 Peptides and Heparin Industry 1.1.1 Overview 1.1.2 Development of Peptides and Heparin 1.2 Market Segment 1.2.1 Upstream 1.2.2 Downstream 1.3 Cost Analysis 2 Industry Environment 2.1 Policy 2.2 Economics 2.3 Sociology 2.4 Technology 3 Peptides and Heparin Market by Type 3.1 By Type 3.1.1 Insulin 3.1.2 Teriparatide 3.1.3 Liraglutide 3.1.4 Leuprolide 3.1.5 Leuprolide 3.1.6 Exenatide 3.1.7 Calcitonin 3.1.8 Enaxaparin Sodium 3.1.9 Heparin Sodium 3.2 Market Size 3.3 Market Forecast 4 Major Companies List 4.1 Cipla Ltd. (Company Profile, Sales Data etc.) 4.2 Emcure Pharmaceuticals Pvt. Ltd. (Company Profile, Sales Data etc.) 4.3 Gland Pharma Limited (Company Profile, Sales Data etc.) 4.4 Troikaa Pharmaceuticals Ltd. (Company Profile, Sales Data etc.) 4.5 Biological E Limited (Company Profile, Sales Data etc.) 4.6 Bharat Biotech (Company Profile, Sales Data etc.) 4.7 Samarth Life Sciences Pvt. Ltd. (Company Profile, Sales Data etc.) 4.8 VHB Life Sciences Limited (Company Profile, Sales Data etc.) 4.9 Celon Laboratories Pvt. Ltd. (Company Profile, Sales Data etc.) 4.10 United Biotech (P) Limited (Company Profile, Sales Data etc.) 4.11 Biocon Limited (Company Profile, Sales Data etc.) 4.12 Sun Pharmaceutical Industries Ltd. (Company Profile, Sales Data etc.) 4.13 Wockhardt Ltd. (Company Profile, Sales Data etc.) 5 Market Competition 5.1 Company Competition 5.2 Regional Market by Company 6 Market Demand 6.1 Demand Situation 6.1.1 Demand in Diabetes 6.1.2 Demand in Infectious Diseases 6.1.3 Demand in Cancer 6.1.4 Demand in Osteoporosis 6.2 Regional Demand Comparison 6.3 Demand Forecast 7 Region Operation 7.1 Regional Production 7.2 Regional Market 7.3 by Region 7.3.1 North America 7.3.1.1 Overview 7.3.1.2 by Country (U.S., Canada, Mexico) 7.3.2 Europe 7.3.2.1 Overview 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) 7.3.3 Asia-Pacific 7.3.3.1 Overview 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) 7.3.4 South America 7.3.4.1 Overview 7.3.4.2 by Country (Brazil, Argentina etc.) 7.3.5 Middle East & Africa 7.3.5.1 Overview 7.3.5.2 by Country (Saudi Arabia, South Africa etc.) 7.4 Regional Import & Export 7.5 Regional Forecast 8 Marketing & Price 8.1 Price and Margin 8.1.1 Price Trends 8.1.2 Factors of Price Change 8.1.3 Manufacturers Gross Margin Analysis 8.2 Marketing Channel 9 Research Conclusion

Table Upstream Segment of Peptides and Heparin Table Application Segment of Peptides and Heparin Table Global Peptides and Heparin Market 2012-2023, by Application, in USD Million Table Major Company List of Insulin Table Major Company List of Teriparatide Table Major Company List of Liraglutide Table Major Company List of Leuprolide Table Major Company List of Leuprolide Table Major Company List of Exenatide Table Major Company List of Calcitonin Table Major Company List of Enaxaparin Sodium Table Major Company List of Heparin Sodium Table Global Peptides and Heparin Market 2012-2017, by Type, in USD Million Table Global Peptides and Heparin Market 2012-2017, by Type, in Volume Table Global Peptides and Heparin Market Forecast 2017-2023, by Type, in USD Million Table Global Peptides and Heparin Market Forecast 2017-2023, by Type, in Volume Table Cipla Ltd. Overview List Table Peptides and Heparin Business Operation of Cipla Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Emcure Pharmaceuticals Pvt. Ltd. Overview List Table Peptides and Heparin Business Operation of Emcure Pharmaceuticals Pvt. Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Gland Pharma Limited Overview List Table Peptides and Heparin Business Operation of Gland Pharma Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Troikaa Pharmaceuticals Ltd. Overview List Table Peptides and Heparin Business Operation of Troikaa Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Biological E Limited Overview List Table Peptides and Heparin Business Operation of Biological E Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Bharat Biotech Overview List Table Peptides and Heparin Business Operation of Bharat Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Samarth Life Sciences Pvt. Ltd. Overview List Table Peptides and Heparin Business Operation of Samarth Life Sciences Pvt. Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table VHB Life Sciences Limited Overview List Table Peptides and Heparin Business Operation of VHB Life Sciences Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Celon Laboratories Pvt. Ltd. Overview List Table Peptides and Heparin Business Operation of Celon Laboratories Pvt. Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table United Biotech (P) Limited Overview List Table Peptides and Heparin Business Operation of United Biotech (P) Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Biocon Limited Overview List Table Peptides and Heparin Business Operation of Biocon Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Sun Pharmaceutical Industries Ltd. Overview List Table Peptides and Heparin Business Operation of Sun Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Wockhardt Ltd. Overview List Table Peptides and Heparin Business Operation of Wockhardt Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Global Peptides and Heparin Sales Revenue 2012-2017, by Company, in USD Million Table Global Peptides and Heparin Sales Revenue Share, by Company, in USD Million Table Global Peptides and Heparin Sales Volume 2012-2017, by Company, in Volume Table Global Peptides and Heparin Sales Volume Share 2012-2017, by Company, in Volume Table Peptides and Heparin Demand in Diabetes, 2012-2017, in USD Million Table Peptides and Heparin Demand in Diabetes, 2012-2017, in Volume Table Major Consumers in Diabetes Table Peptides and Heparin Demand in Infectious Diseases, 2012-2017, in USD Million Table Peptides and Heparin Demand in Infectious Diseases, 2012-2017, in Volume Table Major Consumers in Infectious Diseases Table Peptides and Heparin Demand in Cancer, 2012-2017, in USD Million Table Peptides and Heparin Demand in Cancer, 2012-2017, in Volume Table Major Consumers in Cancer Table Peptides and Heparin Demand in Osteoporosis, 2012-2017, in USD Million Table Peptides and Heparin Demand in Osteoporosis, 2012-2017, in Volume Table Major Consumers in Osteoporosis Table Regional Demand Comparison List Table Major Application in Different Regions Table Peptides and Heparin Demand Forecast 2017-2023, by Application, in USD Million Table Peptides and Heparin Demand Forecast 2017-2023, by Application, in Volume Table Peptides and Heparin Production 2012-2017, by Region, in USD Million Table Peptides and Heparin Production 2012-2017, by Region, in Volume Table Global Peptides and Heparin Market 2012-2017, by Region, in USD Million Table Global Peptides and Heparin Market Share 2012-2017, by Region, in USD Million Table Global Peptides and Heparin Market 2012-2017, by Region, in Volume Table Global Peptides and Heparin Market Share 2012-2017, by Region, in Volume Table North America Peptides and Heparin Market Size 2012-2017, by Country, in USD Million Table North America Peptides and Heparin Market Size 2012-2017, by Country, in Volume Table Europe Peptides and Heparin Market Size 2012-2017, by Country, in USD Million Table Europe Peptides and Heparin Market Size 2012-2017, by Country, in Volume Table Asia-Pacific Peptides and Heparin Market Size 2012-2017, by Country, in USD Million Table Asia-Pacific Peptides and Heparin Market Size 2012-2017, by Country, in Volume Table South America Peptides and Heparin Market Size 2012-2017, by Country, in USD Million Table South America Peptides and Heparin Market Size 2012-2017, by Country, in Volume Table Middle East & Africa Peptides and Heparin Market Size 2012-2017, by Country, in USD Million Table Middle East & Africa Peptides and Heparin Market Size 2012-2017, by Country, in Volume Table Peptides and Heparin Market Forecast 2017-2023, by Region, in USD Million Table Peptides and Heparin Market Forecast 2017-2023, by Region, in Volume Table Price Factors List Figure Peptides and Heparin Industry Chain Structure Figure Global Peptides and Heparin Market Growth 2012-2017, by Type, in USD Million Figure Global Peptides and Heparin Market Growth 2012-2017, by Type, in Volume Figure North America Peptides and Heparin Market, by Company, in 2018 Figure Europe Peptides and Heparin Market Market, by Company, in 2018 Figure Asia-Pacific Peptides and Heparin Market Market, by Company, in 2018 Figure South America Peptides and Heparin Market Market, by Company, in 2018 Figure Middle East & Africa Peptides and Heparin Market Market, by Company, in 2018 Figure North America Peptides and Heparin Market Size and Growth 2012-2017, in USD Million Figure North America Peptides and Heparin Market Size and Growth 2012-2017, in Volume Figure Europe Peptides and Heparin Market Size and Growth 2012-2017, in USD Million Figure Europe Peptides and Heparin Market Size and Growth 2012-2017, in Volume Figure Asia-Pacific Peptides and Heparin Market Size and Growth 2012-2017, in USD Million Figure Asia-Pacific Peptides and Heparin Market Size and Growth 2012-2017, in Volume Figure South America Peptides and Heparin Market Size and Growth 2012-2017, in USD Million Figure South America Peptides and Heparin Market Size and Growth 2012-2017, in Volume Figure Middle East & Africa Peptides and Heparin Market Size and Growth 2012-2017, in USD Million Figure Middle East & Africa Peptides and Heparin Market Size and Growth 2012-2017, in Volume Figure Marketing Channels Overview